We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Protein Biomarker Panel Detects ASD in Young Boys

By LabMedica International staff writers
Posted on 10 Jul 2017
Print article
Image: Researchers have identified a blood biomarker that may aid in earlier diagnosis of children with autism spectrum disorder, or ASD (Photo courtesy of UT Southwestern Medical Center).
Image: Researchers have identified a blood biomarker that may aid in earlier diagnosis of children with autism spectrum disorder, or ASD (Photo courtesy of UT Southwestern Medical Center).
Two protein biomarkers in the blood can be used as a panel to identify boys with autism spectrum disorder (ASD) with better than 82% accuracy.

ASD, a neurodevelopmental disorder characterized by defective social and communication interactions and restricted and repetitive patterns of behavior, affects approximately 1.5% of children in the United States. Most cases are not diagnosed until about age four, when communication and social disabilities become apparent. Thus, an ASD blood biomarker may enable early diagnosis and/or identification of new therapeutic targets.

To identify potential ASD biomarkers, investigators at the University of Texas Southwestern Medical Center (Dallas, USA) used a multiplex immunoassay method to screen serum samples from ASD and typically developing (TD) boys (30 boys in each group) for differences in 110 proteins.

They reported finding 11 proteins that together could confirm ASD with modest accuracy using multiple training and test sets. Two of the 11 proteins were further tested using a different detection platform and with a larger sample of ASD and TD boys. The two proteins, thyroid-stimulating hormone (TSH) and interleukin-8 (IL-8), had been previously identified as putative biomarkers for ASD.

TSH levels were found to be significantly lower in ASD boys, whereas IL-8 levels were significantly elevated. The diagnostic accuracy for ASD based upon TSH or IL-8 levels alone varied from 74 to 76%, but using both proteins together, the diagnostic accuracy increased to 82%.

"ASD is a very heterogeneous disorder, and if we can identify biomarkers for even a subgroup of ASD patients, then that would be extremely helpful not only for early diagnosis but also for the development of therapeutics," said senior author Dr. Dwight German, professor of psychiatry at the University of Texas Southwestern Medical Center.

The ASD biomarker study was published in the June 2, 2017, online edition of the Journal of Neuroinflammation.

Related Links:
University of Texas Southwestern Medical Center

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more

Pathology

view channel
Image: The new method is quick and easy, and can also be used by non-medical personnel. (Photo courtesy of Zoratto et al. Advanced Science 2024, edited)

New Blood Test Device Modeled on Leeches to Help Diagnose Malaria

Many individuals have a fear of needles, making the experience of having blood drawn from their arm particularly distressing. An alternative method involves taking blood from the fingertip or earlobe,... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.